The First Affiliated Hospital With Nanjing Medical University
Clinical trials sponsored by The First Affiliated Hospital With Nanjing Medical University, explained in plain language.
-
New antibiotics tested in Real-World study for tough infections
Disease control ENROLLING_BY_INVITATIONThis study is looking at how effective and safe neotetracycline drugs (like eravacycline and tigecycline) are for treating gram-negative bacterial infections. Researchers will review medical records of about 400 adults who have drug-resistant infections and have taken these antib…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
New heart pacing technique may reduce heart failure risk in block patients
Disease control OngoingThis study compares a newer pacing method called left bundle branch pacing (LBBP) with standard right ventricular pacing (RVP) in 683 adults with atrioventricular block (a type of heart block). The goal is to see if LBBP better preserves the heart's pumping function and reduces t…
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
Heart pacing combo may cut defibrillator need in heart failure patients
Disease control OngoingThis study compares two initial treatments for people with non-ischemic heart failure and a specific heart block. One group gets standard medications, the other gets medications plus a special heart pacing technique. The goal is to see if the pacing approach improves heart functi…
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Blood test may help prevent esophageal cancer return
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether a blood test can find leftover cancer cells after standard chemoradiotherapy for esophageal cancer. People with a positive test may get extra chemotherapy and immunotherapy to lower the risk of the cancer coming back. The study will enroll 65 adults wi…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC
-
Lung cancer and scarred lungs: a new study seeks answers
Knowledge-focused OngoingThis study looks at 200 people with both lung cancer and a lung scarring condition called pulmonary fibrosis. Researchers want to see how well immunotherapy (a type of cancer treatment) works in these patients and if it causes more side effects. They will also study tumor samples…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 03:55 UTC